Lindsay Rocco | Elixir Health Public Relations |
Matthew Pauls | President and Chief Executive Officer |
Scott Wilhoit | Chief Commercial Officer |
Fred Cohen | Chief Medical Officer |
Brian Davis | Chief Financial Officer |
Annabel Samimy | Stifel |
Justin Kim | Oppenheimer |
Esther Hong | Janney Montgomery Scott |
Francois Brisebois | Laidlaw & Company |
Good day, ladies and gentlemen, and welcome to the Strongbridge Biopharma plc Corporate Update and Second Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, this conference is being recorded.
I’d now like to introduce one of your hosts for today’s conference, Lindsay Rocco of Elixir Health Public Relations.